To evaluate the functional consequences of RGS cancer mutations at the endogenous level, we introduced homozygous AXIN C121F and L106R mutations in HEK293T cells using prime editing and CRISPR/Cas9-assisted knockin, respectively (Figures S2A and S2C). The gene discussed is PITX2; the disease is cancer.